| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.080 | 84.618 | 82.118 | 41.414 | 0 | 0 | 0 | 0 | 0 | 10.517 |
| Total Income - EUR | 1.080 | 84.681 | 82.125 | 41.417 | 5 | 0 | 0 | 0 | 0 | 10.517 |
| Total Expenses - EUR | 1.001 | 68.837 | 77.374 | 46.119 | 772 | 52 | 0 | 0 | 0 | 6.533 |
| Gross Profit/Loss - EUR | 79 | 15.844 | 4.751 | -4.702 | -767 | -52 | 0 | 0 | 0 | 3.984 |
| Net Profit/Loss - EUR | 47 | 14.152 | 3.930 | -5.116 | -767 | -52 | 0 | 0 | 0 | 3.552 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Bioscience Solution Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 100 | 55 | 11 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1.912 | 23.530 | 14.345 | 2.645 | 1.865 | 1.830 | 1.789 | 1.795 | 1.790 | 3.654 |
| Inventories | 0 | 4.529 | 1.129 | 139 | 137 | 134 | 131 | 131 | 131 | 0 |
| Receivables | 675 | 1.489 | 2.267 | 1.193 | 1.170 | 1.148 | 1.122 | 1.126 | 1.122 | -22 |
| Cash | 1.237 | 17.512 | 10.949 | 1.313 | 559 | 548 | 536 | 538 | 536 | 3.676 |
| Shareholders Funds | 92 | 14.242 | 4.030 | -1.160 | -1.904 | -1.920 | -1.877 | -1.883 | -1.877 | 1.029 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.820 | 9.388 | 10.369 | 3.815 | 3.770 | 3.750 | 3.667 | 3.678 | 3.667 | 2.625 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bioscience Solution Srl